Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03288350 |
|---|---|
| Brief Title: | mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA) |
| First Submitted : | September 15, 2017 |
| First Submitted that Met QC Criteria : | September 18, 2017 |
| First Posted : | September 20, 2017 |
| Last Update Submitted that Met QC Criteria : | March 20, 2018 |
| Last Update Posted : | March 22, 2018 |